As previously reported, there are various investigations into a £20m partnership with pharmaceutical giant Roche, and the treatment of staff who raised concerns over the project. But following a new all-staff email, trust chair Christine Outram has been accused of making a “misleading” claim around the extent to which a critical draft report – revealed in December – was “watered down” before being finalised in January. In the email sent last week, Ms Outram claimed “no changes were made to the material” in a critical “addendum” section of the report. But analysis of both the draft and final versions, of which One section of the draft that was deleted from the final version had accused managers, executives and the trust board of an “underlying systemic failure” to implement recommendations from two previous reports, in 2012 and 2018, which would have improved the culture and practices in the research division.